Invizius: Funding, Investors & Team (Oct 2026)
Invizius is developing treatments to help hemodialysis patients live longer, feel better, and suffer fewer cardiovascular complications.
Invizius has raised $10.0M across 3 funding rounds on record, the most recent an undisclosed round of $1.3M announced in Sep 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Invizius Company Profile and Key Stats
Latest funding round on record: Sep 2024.
Invizius Funding Rounds
Invizius raised $7.4M in an undisclosed round announced in May 2021.
10 months later, a Grant of $1.3M was announced in Mar 2022.
2.5 years later, an undisclosed round of $1.3M was announced in Sep 2024.
Invizius Founders and Leadership Team
Contact details for the Invizius team: 2 of 2 have an email address on file.
Start 14-day free trial →Invizius Funding Compared to Other Biotechnology Startups
Invizius' latest round of $1.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Invizius in Biotechnology and Edinburgh
Companies Similar to Invizius
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
Invizius Funding FAQs
What does Invizius do?
Invizius is developing treatments to help hemodialysis patients live longer, feel better, and suffer fewer cardiovascular complications.
How much funding has Invizius raised?
Invizius has raised $10.0M across 3 rounds on record. The most recent is an undisclosed round of $1.3M announced in Sep 2024.
When did Invizius last raise funding?
Invizius' most recent funding round on record is an undisclosed round of $1.3M, announced in Sep 2024.
Who founded Invizius?
FundedIQ lists Andy Herbert (Founder) at Invizius.
Who is the CEO of Invizius?
Richard Boyd is listed as CEO at Invizius.
Where is Invizius headquartered?
Invizius is based in Edinburgh, United Kingdom.
How many employees does Invizius have?
Invizius is in the 11-50 employee band.
How does Invizius' funding compare to other Biotechnology startups?
Invizius' latest round of $1.3M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Invizius Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Invizius is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.